IPSNEWS
COFEPRIS Modernizes Medical Device Framework: What You Need to Know
On July 7, 2025, Mexico’s regulatory authority, COFEPRIS, issued a new decree that substantially revises the classification framework for medical devices, thereby formally repealing the agreements published in 2011 and 2014.
Simplification of Operating License and Modification Process for Products and Services
COFEPRIS has implemented a series of simplification and modernization measures aimed at streamlining procedures and reducing the regulatory burden for establishments. These actions are part of the federal government’s regulatory improvement policies. This update specifically applies to the Operating License.
Convocatoria para asistir a Korea Sourcing Week - 2025
Este año, IPS colaborará estrechamente con Korea SMEs and Startups Agency (KOSME) para convocar e identificar a dos grandes compradores mexicanos del sector cosmético interesados en participar en Korea Sourcing Week 2025, que se llevará a cabo del 3 al 6 de septiembre en Ilsan, Corea del Sur.
Classification Query: A Regulatory Tool for Marketing Your Cosmetics and Dietary Supplements
The classification query submitted to the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is a crucial step in regulating cosmetic products and dietary supplements.
Keys to Efficient Medical Device Importation in Mexico
Importing medical devices into Mexico involves a series of steps regulated by health and customs authorities. Due to their impact on public health, these products must meet specific requirements from their origin through to commercialization. Therefore, proactive planning and specialized advice are essential to avoid setbacks.
Revolutionizing Health Product Access in Mexico: COFEPRIS Embraces Global Regulatory Reliance
COFEPRIS has published a new agreement recognizing the evaluations and approvals from key international regulatory authorities and the WHO Prequalification Program for sanitary registrations of medicines and medical devices. This move, effective 60 business days after publication, aims to expedite access to quality health inputs by adopting a "reliance" approach, simplifying import procedures for essential products during health crises.
Health Transformation: Key Incentives for Investment and Scientific Development in Mexico
This Decree, published in the Official Gazette of the Federation on June 2, 2025, establishes a regulatory framework aimed at promoting investment within Mexico to strengthen the pharmaceutical industry, the production of medicines, health inputs, and medical devices, as well as fostering scientific research. Its main objective is to reduce import dependency and ensure the availability of these essential products, using consolidated public procurement as a lever for economic development.
COFEPRIS: A Catalyst for Investment in Mexico
COFEPRIS is undergoing a significant transformation under "Plan México," aiming to become an agile, transparent, and internationally harmonized agency. This includes a push for 100% digitization of procedures, fostering clinical research, streamlining regulatory pathways, and modernizing the regulatory framework to boost investment and ensure public health.
Cosmetic Product Labeling in Mexico: Essential Requirements
In Mexico, cosmetic product labeling is regulated to ensure consumers receive accurate and sufficient information, enabling them to make safe and informed purchasing decisions. Compliance with these regulations is essential for manufacturers and importers looking to sell their products in the country.
Import Permit for Products: Requirements for Dietary Supplements
To import dietary supplements into Mexico, it is essential to understand the applicable regulations, among which the prior sanitary import permit stands out.
This permit, issued by COFEPRIS, authorizes the entry of food, dietary supplements, and non-alcoholic beverages that comply with Mexico’s current sanitary legislation, allowing their commercialization and distribution in the country.